Literature DB >> 2148316

The alpha subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding.

J Hakimi1, C Seals, J A Kondas, L Pettine, W Danho, J Kochan.   

Abstract

The alpha subunit of the FcERI binds IgE with high affinity. Previous studies have demonstrated that alpha subunit expression requires the presence of beta and/or gamma subunits, and it is not known how these two subunits contribute to the ability of the alpha subunit to bind IgE. In this report, we describe the expression and characterization of a human chimeric alpha subunit. The data demonstrate that high affinity IgE binding does not require the presence of the beta and/or gamma subunits and that this activity is localized to the extracellular domain (residues 26-201) of the human alpha subunit. Permanent cell lines expressing the chimeric receptor were used to characterize the binding parameters of the alpha subunit. These cell lines provide a means of identifying therapeutic agents which may be effective in the treatment/management of allergic diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148316

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Stable "zeta" peptides that act as potent antagonists of the high-affinity IgE receptor.

Authors:  Gerald R Nakamura; Mark E Reynolds; Yvonne M Chen; Melissa A Starovasnik; Henry B Lowman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

2.  Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells.

Authors:  Tracy R Daniels; Richard K Leuchter; Rafaela Quintero; Gustavo Helguera; José A Rodríguez; Otoniel Martínez-Maza; Birgit C Schultes; Christopher F Nicodemus; Manuel L Penichet
Journal:  Cancer Immunol Immunother       Date:  2011-11-30       Impact factor: 6.968

3.  Serum IgE clearance is facilitated by human FcεRI internalization.

Authors:  Alexandra M Greer; Nan Wu; Amy L Putnam; Prescott G Woodruff; Paul Wolters; Jean-Pierre Kinet; Jeoung-Sook Shin
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

4.  Inhibition of an Allergen-Antibody Reaction Related to Japanese Cedar Pollinosis Using DNA Aptamers Against the Cry j 2 Allergen.

Authors:  Kazumasa Ogihara; Nasa Savory; Koichi Abe; Wataru Yoshida; Mitsuru Arakawa; Masahiko Asahi; Seika Kamohara; Kazunori Ikebukuro
Journal:  Nucleic Acid Ther       Date:  2015-10-20       Impact factor: 5.486

Review 5.  Animal models for IgE-meditated cancer immunotherapy.

Authors:  Tracy R Daniels; Otoniel Martínez-Maza; Manuel L Penichet
Journal:  Cancer Immunol Immunother       Date:  2011-12-23       Impact factor: 6.968

Review 6.  IgE immunotherapy against cancer.

Authors:  Lai Sum Leoh; Tracy R Daniels-Wells; Manuel L Penichet
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

7.  The high affinity IgE receptor Fc epsilonRI is expressed by human intestinal epithelial cells.

Authors:  Eva Untersmayr; Giovanna Bises; Philipp Starkl; Charles L Bevins; Otto Scheiner; George Boltz-Nitulescu; Fritz Wrba; Erika Jensen-Jarolim
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

8.  Hydrodynamic studies of a complex between the Fc fragment of human IgE and a soluble fragment of the Fc epsilon RI alpha chain.

Authors:  M B Keown; R Ghirlando; R J Young; A J Beavil; R J Owens; S J Perkins; B J Sutton; H J Gould
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

Review 9.  Immunoglobulin E, what is it good for?

Authors:  Brian T Kelly; Mitchell H Grayson
Journal:  Ann Allergy Asthma Immunol       Date:  2016-03       Impact factor: 6.347

Review 10.  Multisubunit receptors in the immune system and their association with the cytoskeleton: in search of functional significance.

Authors:  S Caplan; M Baniyash
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.